Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Quest Pharmatech Inc V.QPT

Alternate Symbol(s):  QPTFF

Quest PharmaTech Inc. is a Canadian biopharmaceutical company. The Company is developing products to improve the quality of life. It is developing the proprietary, MAb-AR9.6, targeting MUC16 as a diagnostic agent for cancer. MAb-AR9.6 is licensed from the University of Nebraska Medical Centre and is in late preclinical stage development. The Company has a 42.5% ownership interest in OncoQuest... see more

TSXV:QPT - Post Discussion

Quest Pharmatech Inc > Borrowed $1 million of working capital
View:
Post by G1945V on Apr 19, 2022 9:42am

Borrowed $1 million of working capital

I just don't know what to make of this:
"TSX Venture: QPT

EDMONTON, AB, April 19, 2022 /CNW/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") announces that it has borrowed $1 million of working capital funding from one of its investee companies, OncoQuest Inc.

The funding, in the form of 2% interest bearing working capital loans provided by OncoQuest, will be used to support the Company's drug development programs. The Company plans to repay the loans once the Company's investments in its investee companies are monetized.

On a corporate matter, Quest announces the granting of 300,000 stock options to an Officer, at an exercise price of $0.10 per common share, expiring 10 years from the date of grant, subject to TSX Venture Exchange approval, and the exercise of 690,000 stock options by Officers and a consultant all at an exercise price of $0.10 per common share for gross proceeds to the Company of $69,000."


G1945V

Comment by PosNeg1 on Apr 19, 2022 2:20pm
QPT needs cash to keep lights on and pay salaries I guess.
Comment by TrickyGame on Apr 19, 2022 10:14pm
At least the interest rate is reasonably low 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities